FEATURE ARTICLE
Organocatalytic Asymmetric Isomerization
323
25
(5R)-1-Hydroxy-1-oxo-2,5-diphenyl-4,5-dihydro-1H-phos-
phole (19)
Mp 128–131 °C (82% ee); Rf = 0.26 (EtOAc–hexanes, 2:1); [α]D
+46.4 (c 0.6, CH2Cl2; 80% ee); [α]D25 +42.5 (c 0.61, MeOH; 80%
ee).
Regular-scale synthesis:14 A sample of 5b (0.26 g, 0.80 mmol),
which had been recrystallized for enantiomeric enrichment, was
dissolved in MeOH (10 mL). After the addition of 6 M HCl (10
mL), the mixture was stirred for 16 h at 60 °C. After cooling and di-
lution with a small volume of H2O, the mixture was extracted with
CH2Cl2 (3 ×). The organic phase was washed with a small volume
of H2O, dried (MgSO4), and evaporated to leave 19 (0.197 g, 91%)
as a colorless powder; 95% ee (31P NMR).
IR (KBr): 3427 (vs), 2937 (vs), 1598 (m), 1496 (s), 1382 (s), 1175
(vs), 1027 (vs), 937 (s), 761 (vs), 696 cm–1 (vs).
1H NMR (400 MHz, CDCl3): δ = 0.65 (t, J = 7.1 Hz, 6 H), 2.06–2.33
(m, 2 H), 2.38–2.57 (m, 2 H), 2.60–2.85 (m, 4 H), 3.10 (td, J = 12.9,
6.8 Hz, 1 H), 3.64 (ddd, J = 24.6, 12.7, 7.4 Hz, 1 H), 7.19–7.38 (m,
10 HArl).
Large-scale synthesis: To a solution of (5R)-5b (94.5 g, 0.291 mol;
78% ee) in MeOH (1.6 L), aq 6 M HCl (1.6 L) was added and the
mixture heated to 60 °C for 20 h with mechanic stirring. The mix-
ture was cooled and extracted with several portions of CH2Cl2. The
organic phase was dried (MgSO4). After filtration, the solvents were
evaporated in vacuo and the solid residue suspended in a small vol-
ume of chilled MeOH. Filtration and drying under high vacuum
gave 19 (62.1 g, 79%) as a colorless crystalline material; 77% ee
(31P NMR). The enantiomeric excess was determined by 31P NMR
of a solution of 19 (5.5 mg) and quinine (37 mg, 5 equiv) in CDCl3
(0.5 mL); δ(31P) = 51.14 (major), 50.79 (minor).
13C NMR (100 MHz, CDCl3): δ = 14.0 (d, JPC = 2.3 Hz, CH3), 27.9
(d, JPC = 9.0 Hz, CH2), 30.2 (d, JPC = 11.4 Hz, CH2), 37.9 (d, JPC
=
3.1 Hz, CH2), 44.3 (d, JPC = 74.9 Hz, CH), 47.7 (d, JPC = 76.5 Hz,
CH), 126.3 (d, JPC = 2.6 Hz, CH), 126.6 (d, JPC = 2.3 Hz, CH), 127.4
(d, JPC = 4.9 Hz, CH), 128.3 (d, JPC = 2.2 Hz, CH), 128.4 (d, JPC
=
1.8 Hz, CH), 128.9 (d, JPC = 5.0 Hz, CH), 136.5 (d, JPC = 5.1 Hz, C),
137.0 (d, JPC = 4.7 Hz, C).
31P NMR (161 MHz, CDCl3): δ = 59.3.
MS (EI, 70 eV): m/z (%) = 327 (42) M+, 312 (30), 206 (15), 120
(14), 104 (100), 91 (15), 72 (88).
Anal. Calcd for C20H26NOP: C, 73.37; H, 8.00; N, 4.28. Found: C,
73.16; H, 8.09; N, 4.21.
Mp 237–239 °C (77% ee); Rf = 0.26 (EtOAc–MeOH, 3:1); [α]D
+126.4 (c 0.595, CH2Cl2; 76% ee); [α]D +98.4 (c 0.28, CH2Cl2; 76%
ee); [α]D –21.9 (c 0.59, MeOH; 76% ee).
(2R,5R)-1-Hydroxy-1-oxo-trans-2,5-diphenylphospholane (Fi-
aud’s Acid, 1)
IR (KBr): 3439 (w), 3050 (m), 1601 (s), 1494 (s), 1449 (m), 1265
(m), 977 (vs), 755 (vs), 694 (vs), 533 (s), 476 cm–1 (m).
1H NMR (250 MHz, CDCl3): δ = 2.84 (dddd, J = 18.6, 6.5, 2.6, 1.1
Hz, 1 H), 3.13 (dddd, J = 22.0, 18.5, 8.6, 3.8 Hz, 1 H), 3.46 (ddd,
J = 18.6, 8.6, 6.6 Hz, 1 H), 7.11 (ddd, J = 45.5, 3.7, 2.6 Hz, 1 H),
7.21–7.37 (m, 8 HPh), 7.51–7.58 (m, 2 HPh), 10.49 (br s, 1 H).
1H NMR (300 MHz, CD3OD): δ = 2.89 (ddd, J = 18.7, 6.8, 2.7 Hz,
1 H), 3.20 (dddd, J = 21.8, 18.7, 8.7, 3.8 Hz, 1 H), 3.54 (ddd, J =
18.4, 8.7, 6.7 Hz, 1 H), 7.19–7.43 (m, 9 H, 8 HArl + H3), 7.65–7.73
(m, 2 HArl).
By Na/NH3 reduction of 19: Na (0.17 g, 0.370 mmol, 20 equiv) was
dissolved in liquid NH3 (ca. 50 mL) at –78 °C. A solution of
(1R,5R)-19 (0.10 g, 0.370 mmol; 81.5% ee) in THF (2 mL) was add-
ed and the mixture was stirred for 5 min at –78 °C. The reaction was
quenched by addition of solid (NH4)2SO4 (1.00 g, 7.57 mmol, 20.5
equiv), causing the blue solution of the mixture to disappear. After
warming to r.t. with evaporation of NH3 into the hood, the residue
was suspended in a small volume of 2 M HCl and extracted with
CH2Cl2. After evaporation of the solvent, a white solid remained
(0.0978 g, 98%; ratio 1/17 7.7:1; 82% ee). After crystallization (hot
MeOH, ca. 3 mL/mmol), pure product (0.0539 g, 54%) was ob-
tained as colorless solid; ≥ 98% ee.
13C NMR (75 MHz, CD3OD): δ = 35.1 (d, JPC = 17.3 Hz, CH2), 44.4
(d, JPC = 93.7 Hz, CH), 127.5 (d, JPC = 5.7 Hz, CH), 128.0 (d, JPC
=
2.7 Hz, CH), 129.4 (CH), 129.6 (CH), 129.7 (d, JPC = 3.6 Hz, CH),
129.8 (CH), 134.4 (d, JPC = 9.7 Hz, C), 137.4 (d, JPC = 118 Hz, C),
137.6 (d, JPC = 6.1 Hz, C), 143.9 (d, JPC = 35.6 Hz, CH).
31P NMR (101 MHz, CDCl3): δ = 66.39 (s, minor, 12%), 66.28 (s,
major, 88%; 76% ee).
31P NMR (120 MHz, CD3OD): δ = 60.1 (s).
By hydrolysis of 15b: To a solution of (2R,5R)-1-(diethylamino)-1-
oxo-2,5-diphenylphospholane (15b, 0.30 g, 0.916 mmol; 81% ee) in
MeOH (10 mL), 6 M HCl (10 mL) was added and the mixture
stirred for 16 h at 60 °C. The aqueous layer was extracted with
CH2Cl2 and the organic layer washed with a small volume of H2O,
dried (MgSO4), filtered, and evaporated. The residue (0.225 g,
75%) consisted of a white solid; 81% ee (31P NMR).
MS (EI, 70 eV): m/z (%) = 270 (100) M+, 206 (24), 192 (10), 103
(10), 91 (12).
Hydrolysis in ethylene glycol: To a sample of (1R,5R)-15b (116 mg,
0.35 mmol) in ethylene glycol (5 mL), aq 6 M HCl (5 mL) was add-
ed and the mixture stirred at 90 °C for 12 h. The aqueous layer was
extracted with CH2Cl2 (3 × 20 mL). The organic phase washed with
H2O (2 × 10 mL), dried (MgSO4), filtered, and evaporated to leave
the product (94.2 mg, 98%) as a white solid.
Anal. Calcd for C16H15O2P + 0.1 H2O: C, 70.64; H, 5.63. Found: C,
70.64; H, 5.66.
Diastereoselective Reduction of 4,5-Dihydro-1H-phospholes
24
24
[α]D +79.2 (c 0.615, CH2Cl2; 76% ee); [α]D +57.9 (c 0.615,
(2R,5R)-1-(Diethylamino)-1-oxo-2,5-diphenylphospholane
(15b)
MeOH; 76% ee).
Prepared by reduction of (1R,5R)-5b (1.00 g, 3.07 mmol, 81% ee)
with Mg powder (1.49 g, 30.7 mmol, 20 equiv) in MeOH (31 mL,
10 mL/mmol): to a solution of 5b in MeOH at 0 °C, Mg powder was
added and the suspension stirred for 7 h at 0 °C. After quenching
with a small volume of both 2 M HCl and H2O, the product was ex-
tracted with CH2Cl2. The organic phase was dried (MgSO4), fil-
tered, and evaporated. Separation of the crude by column
chromatography (EtOAc) gave 15b (0.362 g, 36%) as a white solid;
82% ee (31P NMR, HPLC). The meso-isomer 16, which was also
formed in this reaction, was not isolated. In a second reaction with
(1R,5R)-5b (482 mg, 1.48 mmol) and Mg (>0.72 g) in MeOH (30
mL) at 0 °C, both meso-16 (257 mg, 53%) and (2R,5R)-15b (148.4
mg, 31%) were isolated.
1H NMR (250 MHz, CDCl3): δ = 1.91–2.15 (m, 2 H), 2.19–2.52 (m,
2 H), 3.01–3.26 (m, 2 H), 7.09–7.36 (m, 10 H), 9.54 (s, 1 H).
13C NMR (100 MHz, CDCl3): δ = 28.4 (d, JPC = 12.2 Hz, CH2), 45.3
(d, JPC = 88.0 Hz, CH), 126.6 (CH), 128.2 (d, JPC = 5.2 Hz, CH),
128.3 (CH), 135.7 (C).
31P NMR (161 MHz, CDCl3): δ = 66.8 (s).
Analytical data correspond to those reported.12b
Analysis of enantiomeric excess by 31P NMR: 1 (4.8 mg, 0.018
mmol) and quinine (33 mg, 0.10 mmol) were dissolved in CDCl3
(0.5 mL). δ(31P) = 52.07 [minor, (S,S)-1], 51.71 [major, (R,R)-1].
© Georg Thieme Verlag Stuttgart · New York
Synthesis 2013, 45, 308–325